A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
Researchers develop drug target to tackle multi-drug resistant lung bacterium.
Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.
In a world-first, Griffith University researchers have used an ultra-high field MRI (7 Tesla) to investigate how COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) mirror the same effects on the brain structure.
Researchers are investigating whether the COVID virus can affect vision and depth-perception of those infected.
COVID-19's Delta strain may use a novel invasion method to cause more damage to the brain, intestine and kidneys.
Ageism, physical and social impediments and pandemic play role in high suicide rates in older adults.
A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.
Griffith University researchers have secured more than $2.6M in NHMRC Ideas Grants.
Living through a global pandemic over the past year has seen all of us expanding our vocabularies. We now understand terms like PPE, social distancing and contact tracing. But just when perhaps we thought we had a handle on most of the terminology, we’re faced with another set of new words: mutation, variant and strain.
